Ivan Murrieta (Iván Murrieta-Alvarez)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Prognostic Factors

Top Venues

Leukemia & lymphoma

JCO global oncology

Hematology (Amsterdam, Netherlands)

This page only lists publications with an associated author ORCID identifier.

Publications

Eloísa Riva, Patricio José Duarte, Bryan Valcarcel, Guillermina Remaggi, Ivan Murrieta, Ariel Corzo, Daniel Del Carpio, Camila Peña, Jule Vasquez, Virginia Bove, Larissa Teixeira, Guilherme Fleury-Perini, Sebastian Yantorno, César Samánez, Sergio Lopresti, Milagros Altamirano, Luis Villela, Guillermo J Ruiz-Arguelles, Guillermo J Ruiz-Delgado, Efreen Montaño, Verónica Verri, Elia Zamora Pérez, Fernando Pérez-Jacobo, Henry Idrobo, Humberto Martínez-Cordero, Brady Ernesto Beltrán-Gárate, Jhoanna Ramírez, Jorge J Castillo, Luis E Malpica-Castillo
Treatment and Survival Outcomes of Waldenstrom Macroglobulinemia in Latin American Patients: A Multinational Retrospective Cohort Study. JCO global oncology 8 (2022)
José Antonio Fernández-Gutiérrez, Oscar A Reyes-Cisneros, Mark R Litzow, Lorena Bojalil-Alvarez, Elizabeth Garcia-Villaseñor, Eliezer Tomas Gómez-Gomez, Ivan Murrieta, Guillermo José Ruiz Argüelles, Cesar Homero Gutiérrez-Aguirre, Amado J Karduss-Urueta, Guillermo J Ruiz-Delgado, Guillermo José Ruiz-Arguelles
High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Lorena Bojalil-Alvarez, Morie A Gertz, Elizabeth Garcia-Villaseñor, José Antonio Fernández-Gutiérrez, Oscar Alfonso Reyes-Cisneros, Ivan Murrieta, Yahveth Cantero-Fortiz, Guillermo J Ruiz-Delgado, Guillermo José Ruiz-Arguelles
Long term survival in multiple myeloma: a single institution experience in underprivileged circumstances. Leukemia & lymphoma 63 (5) (2021)